drugset / Trial / NCT01288157
A Study of the Pharmacokinetics of Golimumab in Chinese Male Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics of golimumab in Chinese male participants.
Timeline
- Start
- 2010-09
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Golimumab | Monoclonal antibody | 50 mg | — |
| Subject | Golimumab | Monoclonal antibody | 100 mg | — |
Indications
No indication recorded.